Chapter Home Raises $6.6M to Redefine Chinese Home Living

Zhibao Technology

At Zhibao Technology Inc., we are the pioneers and market leaders in the 2B2C embedded digital insurance solutions market in China. Our mission is to revolutionize the insurance industry through cutting-edge technology and innovative solutions. 🔹 Our Innovation: With over 40+ customized insurance solutions, we cover a wide range of industries, ensuring that we meet the diverse needs of our partners and their customers. Our proprietary, PaaS-based digital insurance brokerage platform is the first of its kind in the 2B2C sector in China, empowering our business to expand and scale rapidly. 🔹 Our Reach: We have successfully partnered with over 1,000 business channels (B channels), allowing us to seamlessly integrate our insurance solutions into their customer engagement platforms. Through these partnerships, we have already served the various insurance needs of more than 1 million customers. 🔹 Why Choose Zhibao? Market Leadership: We are the frontrunners in the 2B2C digital insurance market in China, setting new standards for the industry. Innovative Solutions: Our 40+ customized insurance products ensure comprehensive coverage across multiple industries. Scalable Platform: Our PaaS-based digital brokerage platform is designed for rapid expansion and scalability, offering immense growth potential. Proven Success: With over 1,000 partnerships and 1 million satisfied customers, our track record speaks for itself. Zhibao is not just leading the market; we are shaping the future of digital insurance. As we continue to innovate and expand, we offer a unique and lucrative opportunity for investors to join us on this exciting journey. Join us at Zhibao Technology Inc. and be a part of the digital insurance revolution!

GeneMind Biosciences

Founded in 2012, GeneMind Biosciences is a biotech company located in Shenzhen, China. We are dedicated to developing cutting-edge genome sequencing technologies and tools that can be widely used for every person's healthcare. We believe that genome sequencing is one of the most powerful technologies of the 21st century. By sequencing the millions of individuals, the big data of personal DNA information can bring us closer to curing diseases like cancer and rare genetic diseases, and we can collectively change the world for the better.

Shanghai Xisiid Intelligence Technology Co., Ltd.

Xisiid Intelligence: Empowering the Future with Brain-Inspired AGI Xisiid Intelligence deeply integrates computational neuroscience with Artificial Intelligence. By drawing inspiration from biological brain mechanisms, we create "Intelligent Digital Twins" for both enterprises and individuals. Through locally deployable brain-like models and brain-inspired memory systems, we build autonomous, privacy-preserving, and self-learning brain-like agents dedicated to serving the individual. Our technology is designed to solve the critical pain points of current large language models (LLMs), such as excessive token consumption, limited memory span, hallucinations, and poor autonomous skill acquisition. On a commercial scale, by equipping every user with a personalized digital assistant, we aim to drive the interconnected collaboration of hundreds of millions of intelligent twins—eventually triggering the emergence of system-level AGI and reconstructing a multi-trillion-dollar intelligent economic ecosystem. Xisiid Intelligence was founded by the Chief Scientist of the National Brain Project and a recipient of the National Talent Program. Our core team brings together top-tier algorithm experts, engineers, and serial entrepreneurs from world-class universities and leading AI tech giants, possessing deep capabilities in technological innovation, engineering execution, and commercialization.